Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kim, Gi Jeong ^a   Rhee, Hyungjin ^a   Yoo, Jeong Eun ^a   Ko, Jung Eun ^a   Lee, Jee San ^a   Kim, Hyunki ^a   Choi, Jin Sub ^a   Park, Young Nyun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYTOKERATIN 19; EPITHELIAL MEMBRANE ANTIGEN; FIBROBLAST ACTIVATION PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; CTGF PROTEIN, HUMAN; GELATINASE; MUCIN 1; SEPRASE; SERINE PROTEINASE; TUMOR MARKER;

ADULT; AGED; AGGRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STROMA; TISSUE MICROARRAY; TOPOGRAPHY; TUMOR MICROENVIRONMENT; TUMOR VOLUME; VERY ELDERLY; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE-FREE SURVIVAL; FEMALE; GELATINASES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUCIN-1; PROPORTIONAL HAZARDS MODELS; SERINE ENDOPEPTIDASES; TUMOR MICROENVIRONMENT;

EID: 84931353780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105094     Document Type: Article

References (40)

1. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433.
2. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851. (Pubitemid 38174665)
3. Jing Y, Han Z, Zhang S, Liu Y, Wei L (2011) Epithelial-Mesenchymal Transition in tumor microenvironment. Cell Biosci 1: 29.
4. Campbell NE, Kellenberger L, Greenaway J, Moorehead RA, Linnerth-Petrik NM, et al. (2010) Extracellular matrix proteins and tumor angiogenesis. J Oncol 2010: 586905.
5. Yang JD, Nakamura I, Roberts LR (2011) The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 21: 35-43.
6. Aboussekhra A (2011) Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55: 841-849.
7. Hafner C, Reichle A, Vogt T (2005) New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy. Curr Cancer Drug Targets 5: 393-419. (Pubitemid 41176178)
8. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
9. Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, et al. (2012) Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21: 488-503.
10. Rasanen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Exp Cell Res 316: 2713-2722.
11. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
12. Seok JY, Na DC, Woo HG, Roncalli M, Kwon SM, et al. (2012) A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 55: 1776-1786.
13. Brigstock DR (2010) Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J Cell Commun Signal 4: 1-4.
14. Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, et al. (2010) Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 51: 523-534.
15. von Mensdorff-Pouilly S, Snijdewint FG, Verstraeten AA, Verheijen RH, Kenemans P (2000) Human MUC1 mucin: a multifaceted glycoprotein. Int J Biol Markers 15: 343-356. (Pubitemid 32041150)
16. Coulouarn C, Corlu A, Glaise D, Guenon I, Thorgeirsson SS, et al. (2012) Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res 72: 2533-2542.
17. Ichikawa T, Yamamoto T, Uenishi T, Tanaka H, Takemura S, et al. (2006) Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13: 245-251.
18. Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, et al. (2008) Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol 39: 126-136. (Pubitemid 350216169)
19. Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, et al. (2012) MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One 7: e49251.
20. Kim SM, Oh SJ, Hur B (2012) Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. Korean J Pathol 46: 429-435.
21. Henriksson ML, Edin S, Dahlin AM, Oldenborg PA, Oberg A, et al. (2011) Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am J Pathol 178: 1387-1394.
22. Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, et al. (2007) Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 13: 1736-1741. (Pubitemid 46952939)
23. Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, et al. (2012) Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol 18: 840-846.
24. Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, et al. (2013) High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumour Biol 34: 1013-1020.
25. Niedermeyer J, Kriz M, Hilberg F, Garin-Chesa P, Bamberger U, et al. (2000) Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol 20: 1089-1094. (Pubitemid 30044246)
26. Mathew S, Scanlan MJ, Mohan Raj BK, Murty VV, Garin-Chesa P, et al. (1995) The gene for fibroblast activation protein alpha (FAP), a putative cell surface-bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23. Genomics 25: 335-337.
27. Yuan SF, Li KZ, Wang L, Dou KF, Yan Z, et al. (2005) Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue. World J - Gastroenterol 11: 4661-4666. (Pubitemid 41179519)
28. di Mola FF, Friess H, Martignoni ME, Di Sebastiano P, Zimmermann A, et al. (1999) Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 230: 63-71. (Pubitemid 30190366)
29. Gupta S, Clarkson MR, Duggan J, Brady HR (2000) Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58: 1389-1399.
30. Rachfal AW, Brigstock DR (2003) Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 26: 1-9. (Pubitemid 36939924)
31. Chen CM, Wang LF, Chou HC, Lang YD, Lai YP (2007) Up-regulation of connective tissue growth factor in hyperoxia-induced lung fibrosis. Pediatr Res 62: 128-133.
32. Kwon S, Munroe X, Crawley SC, Lee HY, Spong S, et al. (2007) Expression of connective tissue growth factor in pancreatic cancer cell lines. Int J Oncol 31: 693-703.
33. Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, et al. (2011) Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. Oncologist 16: 1028-1039.
34. Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J, et al. (2013) Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone. J Cancer Res Clin Oncol 139: 669-679.
35. Xiu M, Liu YH, Brigstock DR, He FH, Zhang RJ, et al. (2012) Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth. World J Gastroenterol 18: 7070-7078.
36. Kim H, Choi GH, Na DC, Ahn EY, Kim GI, et al. (2011) Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 54: 1707-1717.
37. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, et al. (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71: 614-624.
38. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, et al. (2010) Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956.
39. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
40. Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13: e83-89.